Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 8 November 2019. Kevin Lobo.

Executive Summary

Stryker is acquiring rival Wright Medical in a $4bn deal catapulting the company to a top position in the trauma and extremities market. See what Stryker CEO Kevin Lobo said about it here.

“With Wright Medical, Stryker will be a leading player in the fast-growing $5bn extremities market. As we look at Wright Medical's comprehensive, highly competitive portfolio, Stryker will meaningfully bolster its ability to compete and innovate in the nearly $2bn global shoulder market, where we have been sub-scale for years. When we unite, we will have leading offerings in upper and lower extremities and biologics, which will enhance our capabilities in the orthopedic market.” – Kevin Lobo, CEO, Stryker Corp.

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125878

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel